Cargando…

Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells

In this paper, we compared the effects of bortezomib on L1210 (S) cells with its effects on P-glycoprotein (P-gp)-positive variant S cells, which expressed P-gp either after selection with vincristine (R cells) or after transfection with a human gene encoding P-gp (T cells). Bortezomib induced the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyca, Tomáš, Pavlíková, Lucia, Boháčová, Viera, Mišák, Anton, Poturnayová, Alexandra, Breier, Albert, Sulová, Zdena, Šereš, Mário
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197160/ https://www.ncbi.nlm.nih.gov/pubmed/34071136 http://dx.doi.org/10.3390/ijms22115504

Ejemplares similares

L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins
por: Pavlikova, Lucia, et al.
Publicado: (2017)

Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic Reticulum
por: Šereš, Mário, et al.
Publicado: (2020)

Triorganotin Derivatives Induce Cell Death Effects on L1210 Leukemia Cells at Submicromolar Concentrations Independently of P-glycoprotein Expression
por: Bohacova, Viera, et al.
Publicado: (2018)

The Roles of microRNAs in Cancer Multidrug Resistance
por: Pavlíková, Lucia, et al.
Publicado: (2022)

Screening of Phenanthroquinolizidine Alkaloid Derivatives for Inducing Cell Death of L1210 Leukemia Cells with Negative and Positive P-glycoprotein Expression
por: Kubíčková, Jana, et al.
Publicado: (2019)

Interplay between P-Glycoprotein Expression and Resistance to Endoplasmic Reticulum Stressors
por: Hano, Milan, et al.
Publicado: (2018)

Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells
por: Cagala, Martin, et al.
Publicado: (2020)

Potentiation of Anticancer Drugs: Effects of Pentoxifylline on Neoplastic Cells
por: Barancik, Miroslav, et al.
Publicado: (2011)

Cell Death Effects Induced by Sulforaphane and Allyl Isothiocyanate on P-Glycoprotein Positive and Negative Variants in L1210 Cells
por: Kontar, Szilvia, et al.
Publicado: (2020)

Detection of Glycomic Alterations Induced by Overexpression of P-Glycoprotein on the Surfaces of L1210 Cells Using Sialic Acid Binding Lectins
por: Bubencíkova, Tatiana, et al.
Publicado: (2012)

Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol
por: Šimoničová, Kristína, et al.
Publicado: (2023)

Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1/GAL-9/TIM-3 Signaling Pathway
por: Kocibalova, Zuzana, et al.
Publicado: (2021)

Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter
por: Elefantova, Katarina, et al.
Publicado: (2018)

Tunicamycin Depresses P-Glycoprotein Glycosylation Without an Effect on Its Membrane Localization and Drug Efflux Activity in L1210 Cells
por: Šereš, Mário, et al.
Publicado: (2011)

Changes in Apoptotic Pathways in MOLM-13 Cell Lines after Induction of Resistance to Hypomethylating Agents
por: Janotka, Ľuboš, et al.
Publicado: (2021)

Effects of Sulforaphane-Induced Cell Death upon Repeated Passage of Either P-Glycoprotein-Negative or P-Glycoprotein-Positive L1210 Cell Variants
por: Bertova, Anna, et al.
Publicado: (2022)

Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody
por: Zhang, Xuemei, et al.
Publicado: (2013)

Erratum to “Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody”
por: Zhang, Xuemei, et al.
Publicado: (2014)

Bortezomib-Based Regimens and Plasma Cell Leukemia
por: Bolaman, Ali Zahit
Publicado: (2021)

MDR1 Polymorphisms and Idiopathic Nephrotic Syndrome in Slovak Children: Preliminary Results
por: Cizmarikova, Martina, et al.
Publicado: (2015)

N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
por: Vine, Kara L., et al.
Publicado: (2016)

Update on treatment of follicular non-Hodgkin’s lymphoma: focus on potential of bortezomib
por: Brander, Danielle M, et al.
Publicado: (2012)

Bortezomib
por: Rajappa, Senthil
Publicado: (2010)

Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo
por: Sui, Hua, et al.
Publicado: (2013)

MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression in vitro
por: Xie, Yangmei, et al.
Publicado: (2018)

Progress on the Application of Bortezomib and Bortezomib-Based Nanoformulations
por: Liu, Jianhao, et al.
Publicado: (2021)

Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia
por: Tanturli, Michele, et al.
Publicado: (2011)

Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia
por: Du, Xin, et al.
Publicado: (2017)

Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport
por: Sadiq, Muhammad Waqas, et al.
Publicado: (2015)

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays
por: Kappelmayer, János, et al.
Publicado: (2013)

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013)

Extreme low dose of 5-fluorouracil reverses MDR in cancer by sensitizing cancer associated fibroblasts and down-regulating P-gp
por: Ma, Yan, et al.
Publicado: (2017)

Emergence in Western African Countries of MDR-TB, Focus on Côte d'Ivoire
por: Ekaza, Euloge, et al.
Publicado: (2013)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy
por: Zhao, Junmei, et al.
Publicado: (2015)

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia
por: La Starza, Roberta, et al.
Publicado: (2019)

Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia
por: Wirth, Ingrid M., et al.
Publicado: (2020)

MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia
por: Lardo, Mabel, et al.
Publicado: (2015)

The Antagonism of the Prokineticin System Counteracts Bortezomib Induced Side Effects: Focus on Mood Alterations
por: Amodeo, Giada, et al.
Publicado: (2021)

Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
por: Walsh, Naomi, et al.
Publicado: (2009)

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines
por: Bollmann, Lukas M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pmdupj8geepifi0n4pi1h32o5s